9 studies found for:    pulmonary alveolar proteinosis
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis
Conditions: Pulmonary Alveolar Proteinosis;   Primary Disease
Intervention: Drug: rituximab
2 Completed Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)
Condition: Hereditary Pulmonary Alveolar Proteinosis
Intervention: Drug: Leukine
3 Enrolling by invitation Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP)
Condition: Pulmonary Alveolar Proteinosis
Interventions: Drug: GM-CSF [Leukine (Sargramostim)];   Procedure: WLL
4 Unknown  GM-CSF in Patients With Pulmonary Alveolar Proteinosis
Condition: Pulmonary Alveolar Proteinosis
Intervention: Drug: GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)
5 Recruiting Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
Condition: Pulmonary Alveolar Proteinosis
Interventions: Drug: rhGM-CSF;   Procedure: Whole Lung Lavage(WLL)
6 Recruiting Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT
Condition: Pulmonary Alveolar Proteinosis (PAP).
Interventions: Device: MRI;   Radiation: Research CT if clinical one is complete before the pre lavage
7 Recruiting Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Conditions: Anticytokine Autoantibody-Associated Diseases;   Nontuberculous Mycobacterial Infection;   Mucocutaneous Candidiasis;   Pulmonary Alveolar Proteinosis
Intervention: Drug: Rituximab intravenous infusions 375 m
8 Recruiting Natural History Study of GATA2 Deficiency and Related Disorders
Conditions: Myelodysplasia;   Monocytopenia;   B Cell Lymphopenia;   NK Cell Deficiency;   Warts
Intervention:
9 Recruiting Epidemiology of Surfactant Protein-B Deficiency
Conditions: Lung Diseases;   Respiratory Distress Syndrome, Newborn;   Surfactant Deficiency
Intervention:

Indicates status has not been verified in more than two years